These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24475827)

  • 21. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
    Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
    Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
    Shen S; Zhou W; Chen X; Zhang J;
    Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF Apo-E levels associate with cognitive decline and MRI changes.
    Toledo JB; Da X; Weiner MW; Wolk DA; Xie SX; Arnold SE; Davatzikos C; Shaw LM; Trojanowski JQ;
    Acta Neuropathol; 2014 May; 127(5):621-32. PubMed ID: 24385135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.
    Mori E; Lee K; Yasuda M; Hashimoto M; Kazui H; Hirono N; Matsui M
    Ann Neurol; 2002 Feb; 51(2):209-14. PubMed ID: 11835377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dementia, quantitative neuroimaging, and apolipoprotein E genotype.
    Bigler ED; Lowry CM; Anderson CV; Johnson SC; Terry J; Steed M
    AJNR Am J Neuroradiol; 2000; 21(10):1857-68. PubMed ID: 11110538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of APOE in mild cognitive impairment.
    Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
    Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort.
    Habes M; Toledo JB; Resnick SM; Doshi J; Van der Auwera S; Erus G; Janowitz D; Hegenscheid K; Homuth G; Völzke H; Hoffmann W; Grabe HJ; Davatzikos C
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1636-42. PubMed ID: 27173368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.
    Murphy EA; Roddey JC; McEvoy LK; Holland D; Hagler DJ; Dale AM; Brewer JB;
    Brain Imaging Behav; 2012 Mar; 6(1):16-26. PubMed ID: 21892657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.